![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.newswise.com/articles/betamethasone-could-improve-outcomes-for-prostate-cancer-radiation-therapy#:~:text=Betamethasone%20could%20improve%20outcomes%20for%20prostate%20cancer%20radiation%20therapy,-Released%3A%2012%2DAug&text=Newswise%20%E2%80%94%20A%20new%20study%20published,radiation%20treatments%20for%20prostate%20cancer.
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fagron-group-bv-624255-06142022
https://health.economictimes.indiatimes.com/news/pharma/glenmark-receives-anda-approval-for-topical-treatment-of-plaque-psoriasis-in-adults/91434978
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-22-2021-1632297403.pdf
https://www.prnewswire.com/news-releases/epi-health-and-mc2-therapeutics-announces-us-launch-of-wynzora-cream-for-plaque-psoriasis-calcipotriene-and-betamethasone-dipropionate-ww-0-0050-064-301332247.html
https://www.accesswire.com/653992/Highly-Significant-Head-to-Head-Data-for-WynzoraR-Cream-calcipotriene-and-betamethasone-dipropionate-ww-00050064-for-the-Treatment-of-Plaque-Psoriasis-Accepted-to-Maui-Derm-Summer-Meeting
https://via.tt.se/pressmeddelande/mc2-therapeutics-announces-submission-of-marketing-authorization-application-in-eu-for-wynzora-cream-50-gg-calcipotriol-and-05-mgg-betamethasone-as-dipropionate?publisherId=259167&releaseId=3280035
https://www.biospectrumasia.com/news/39/16250/lipidor-cadila-to-conduct-ph-iii-study-of-anti-psoriasis-candidate.html
https://www.biospace.com/article/releases/encore-dermatology-inc-acquires-sernivo-trianex-and-promiseb-/?s=79
https://www.pharmacompass.com/pdf/news/recipharm-ltd-fails-edqm-inspection-1540034321.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf
http://www.pharmabiz.com/NewsDetails.aspx?aid=86560&sid=1